Holdings
Invesco Pharmaceuticals ETF
As of Jul 31, 2026, Invesco Pharmaceuticals ETF reported 28 positions worth US$472M. Largest: Abbott Laboratories, Abbvie Inc. and Amgen Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abbott Laboratories | 253K | US$26.8M | +99,245 | Jul 31, 2026 |
| Abbvie Inc. | 103K | US$25.9M | +25,771 | Jul 31, 2026 |
| Amgen Inc. | 65,359 | US$25.2M | +19,258 | Jul 31, 2026 |
| Johnson & Johnson | 95,373 | US$24.4M | +23,676 | Jul 31, 2026 |
| Merck & Company, Inc. | 183K | US$23.9M | +40,941 | Jul 31, 2026 |
| Eli Lilly And Company | 20,622 | US$23.7M | +3,668 | Jul 31, 2026 |
| Corcept Therapeutics Incorporated | 205K | US$23.4M | −63,348 | Jul 31, 2026 |
| Gilead Sciences, Inc. | 164K | US$21.4M | +44,629 | Jul 31, 2026 |
| Pfizer, Inc. | 849K | US$21.2M | +199K | Jul 31, 2026 |
| Amneal Pharmaceuticals, Inc. | 966K | US$17.7M | +299K | Jul 31, 2026 |